Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAT-2003 in Severe Hypertriglyceridemia
NCT01968720Phase 2Completed
- Sponsor
- Astria Therapeutics
- Start
- Oct 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of CAT-2003 in hypertriglyceridemia, sponsored by Astria Therapeutics. Started Oct 2013; status: completed.
02
Drugs
CAT-2003
03
Conditions
hypertriglyceridemia
Beyond the preview
Go deeper on NCT01968720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968720.